Chimeric Antigen Receptor (CAR)-T Cell Therapy for Non-Hodgkin's Lymphoma

This review focuses on the use of chimeric antigen receptor (CAR)-T cell therapy to treat non-Hodgkin's lymphoma (NHL), a classification of heterogeneous malignant neoplasms of the lymphoid tissue. Despite various conventional and multidrug chemotherapies, the poor prognosis for NHL patients re...

Full description

Saved in:
Bibliographic Details
Main Authors: Maria Giraudo (Author), Zachary Jackson (Author), Indrani Das (Author), Olubukola Abiona (Author), David Wald (Author)
Format: Book
Published: Case Western Reserve University, 2024-03-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!